Experts stress need for ‘careful monitoring and discussion’ if opioids are prescribed to older adults with Alzheimer’s and other dementias.
Opioid use could put dementia patients at a higher risk of death, particularly in the first two weeks after starting a medication, according to new research revealed on Tuesday at the Alzheimer’s Association International Conference in Amsterdam.
The risk was even higher among those who used fentanyl patches, with nearly two-thirds of those patients dying within 180 days, the Alzheimer’s Association reported. “Our study shows the importance of careful evaluation of risk and benefits to the patient when considering initiating opioid therapy among elderly individuals with dementia.”
“These new findings further emphasize the need for discussion between the patient, family and physician,” Purcell continued.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Be careful of snakes during record-high temperatures: APA!During this record heat, residents and pet owners should be snake-aware and look out for their animals, says Austin Pets Alive!
Leer más »
Higher risk of death from any opioid use in people with dementia, study says | CNNTaking any kind of opioid to reduce pain raised the risk of death 11-fold during the first two weeks for people over 65 diagnosed with dementia, a new study found.
Leer más »
Crosswords, Crafts Linked to Dementia Prevention: StudyOlder people who use computers, take classes, or do crossword puzzles may be enjoying activities that ultimately reduce their risk of having dementia, a new study shows.
Leer más »
Hearing aids may reduce your risk of dementia by half, study says | CNNResearchers have known for a decade that hearing loss increases a person’s risk for cognitive decline, but there wasn’t enough evidence to know if that could be mitigated by hearing aids. In the first randomized control trial, scientists have found some hope.
Leer más »
Drug donanemab seen as turning point in dementia fightThe antibody treatment donanemab slows clinical decline by around a third, a large trial confirms.
Leer más »
How COVID-19 Affects the Brain, Even Long After an InfectionScientists Are Just Beginning to Understand COVID-19's Effect On the Brain
Leer más »